scholarly journals Mathematical Models for Intraoperative Prediction of Metastasis to Lymph Nodes in the Hilar-intrapulmonary or the Mediastinal Region in Patients With Clinical Stage I Non-small Cell Lung Cancer: a Retrospective Cohort Study

Author(s):  
Yue Zhou ◽  
Junjie Du ◽  
Changhui Ma ◽  
Fei Zhao ◽  
Hai Li ◽  
...  

Abstract Background: It remains challenging to determine the regions of metastasis to lymph nodes during operation for clinical stage I non-small cell lung cancer (NSCLC). This study aimed to establish intraoperative mathematical models with nomograms for predicting the hilar-intrapulmonary node metastasis (HNM) and the mediastinal node metastasis (MNM) in patients with clinical stage I NSCLC.Methods: The clinicopathological variables of 585 patients in a derivation cohort who underwent thoracoscopic lobectomy with complete lymph node dissection were retrospectively analysed for their association with the HNM or the MNM. After analysing the variables, we developed multivariable logistic models with nomograms to estimate the risk of lymph node metastasis in different regions. The predictive efficacy was then validated in a validation cohort of 418 patients.Results: It was confirmed that CEA (> 5.75 ng/ml), CYFRA211 (> 2.85 ng/ml), the maximum diameter of tumour (> 2.75 cm), tumour differentiation (grade III), bronchial mucosa and cartilage invasion, and vascular invasion were predictors of HNM, and CEA (>8.25 ng/ml), CYFRA211 (> 2.95 ng/ml), the maximum diameter of tumour (> 2.75 cm), tumour differentiation (grade III), bronchial mucosa and cartilage invasion, vascular invasion, and visceral pleural invasion were predictors of MNM. The validation of the prediction models based on the above results demonstrated good discriminatory power.Conclusions: Our predictive models are helpful in the decision‑making process of specific therapeutic strategies for the regional lymph node metastasis in patients with clinical stage I NSCLC.

Lung Cancer ◽  
2007 ◽  
Vol 57 (3) ◽  
pp. 311-316 ◽  
Author(s):  
Nobukazu Fuwa ◽  
Tetsuya Mitsudomi ◽  
Takashi Daimon ◽  
Yasushi Yatabe ◽  
Masahiro Shinoda ◽  
...  

2019 ◽  
Vol 10 (7) ◽  
pp. 1597-1604 ◽  
Author(s):  
Zhirong Zhang ◽  
Jinbai Miao ◽  
Qirui Chen ◽  
Yili Fu ◽  
Hui Li ◽  
...  

2021 ◽  
Author(s):  
Jie Zhao ◽  
Wenlu Hang ◽  
Qian Wang ◽  
Yonghong Xu

Abstract Background: Non-small cell lung cancer (NSCLC) is a disease with quite grave prognosis. This study explored the diagnostic efficiency of miR-126-5p and miR-34c-3p in serum extracellular vesicles (EVs) in NSCLC patients.Methods: Serum EVs were extracted from NSCLC patients and healthy people and verified. The expression of miR-126-5p and miR-34c-3p in serum EVs were tested. Correlation of miR-126-5p and miR-34c-3p expression and diagnosis, prognosis and pathological characteristics (age, gender, tumor size, clinical stage, and lymph node metastasis) of NSCLC patients was analyzed. The downstream targets of miR-126-5p and miR-34c-3p were predicted and their roles in diagnosis and prognosis of NSCLC patients were evaluated.Results: miR-126-5p and miR-34c-3p were poorly expressed in serum EVs of NSCLC patients and their low expressions were associated with clinical stage, lymph node metastasis and prognosis of NSCLC patients and could be used as biomarkers for diagnosis. As the common target genes of miR-126-5p and miR-34c-3p, LYPLA1 and CDK6 were highly expressed in serum EVs and were associated with poor prognosis in NSCLC patients.Conclusion: Lowly expressed miR-126-5p and miR-34c-3p in serum EVs of NSCLC patients can serve as biomarkers for diagnosis and are linked with prognosis. As common targets of miR-126-5p and miR-34c-3p, LYPLA1 and CDK6 are also associated with poor prognosis in NSCLC patients.


2013 ◽  
Vol 96 (1) ◽  
pp. 239-245 ◽  
Author(s):  
Sukki Cho ◽  
In Hag Song ◽  
Hee Chul Yang ◽  
Kwhanmien Kim ◽  
Sanghoon Jheon

Sign in / Sign up

Export Citation Format

Share Document